Hint mode is switched on Switch off

XPH - SPDR® S&P® Pharmaceuticals ETF (USD) (US78464A7220)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Choose all Reset all
 
(%)
US78464A7220
XPH ISIN
Exchange Traded Funds (ETF)
Type of fund
SPDR State Street Global Advisors
Provider
56.31 USD
NAV per Share | 03/06/2026
16/06/2006
Inception Date
4 times per year
Dividend payments
CEOILS
CFI
XPH
Ticker
Formed
Status
Equity
Investment category
Healthcare
Sector
USA
Investor locations
S&P Pharmaceuticals Select Industry Index
Benchmark
0.35 %
Total Cost Ratio
335.05 mln USD
Fund NAV | 03/06/2026
335.05 mln USD
Share Class NAV | 03/06/2026
No
UCITS

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Yield on 03/06/2026, NYSE Arca

  • YTD
    1.13 %
  • 1M
    -5.91 %
  • 3M
    -2.73 %
  • 6M
    7.29 %
  • 1Y
    38.48 %
  • 3Y
    42.34 %
  • 5Y
    18.07 %
  • 10Y
    47.64 %
At the price on the exchange, taking into account income payments

Latest data on
Add to compare
from
to
ADD-IN
Cbonds add-in API
bond data api

Quotes (XPH)

Explore the most comprehensive database

1 000 000

bonds

80 234

stocks

167 970

ETF & Funds

70 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Price dynamics

Fund profile

The SPDR S&P Pharmaceuticals ETF seeks to replicate as closely as possible the price and yield performance of the S&P Pharmaceuticals Select Industry Index by investing in a portfolio comprised primarily of U.S. companies in the pharmaceutical industry

XPH profile

The SPDR® S&P® Pharmaceuticals ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in USA. The SPDR State Street Global Advisors fund’s base currency is USD and the share class was registered 16.06.2006 with unique ISIN - US78464A7220. Main exchange is NYSE Arca and ticker symbol is XPH. The total expense ratio is 0.35%. The SPDR® S&P® Pharmaceuticals ETF (USD) pays dividends 4 time(s) per year.

Structure XPH on 02/06/2026

Download structure in Excel
Paper Value
CORCEPT THERAPEUTICS INC 4%
ORGANON + CO 3.96%
LIQUIDIA CORP 2.71%
AXSOME THERAPEUTICS INC 2.64%
DEFINIUM THERAPEUTICS INC 2.33%
JAZZ PHARMACEUTICALS PLC 2.31%
EDGEWISE THERAPEUTICS INC 2.28%
ESPERION THERAPEUTICS INC 2.21%
ENLIVEN THERAPEUTICS INC 2.19%
ROYALTY PHARMA PLC CL A 2.19%
TREVI THERAPEUTICS INC 2.14%
VIATRIS INC 2.13%
HARMONY BIOSCIENCES HOLDINGS 2.03%
NUVATION BIO INC 2.02%
PERRIGO CO PLC 2.02%
ELI LILLY + CO 2.02%
LIGAND PHARMACEUTICALS 1.99%
MBX BIOSCIENCES INC 1.98%
INDIVIOR PHARMACEUTICALS INC 1.95%
ELANCO ANIMAL HEALTH INC 1.91%
AMNEAL PHARMACEUTICALS INC 1.89%
MERCK + CO. INC. 1.89%
XERIS BIOPHARMA HOLDINGS INC 1.88%
ANI PHARMACEUTICALS INC 1.85%
PACIRA BIOSCIENCES INC 1.85%
INNOVIVA INC 1.8%
PFIZER INC 1.77%
JOHNSON + JOHNSON 1.74%
BRISTOL MYERS SQUIBB CO 1.72%
AMYLYX PHARMACEUTICALS INC 1.69%
HARROW INC 1.69%
CRINETICS PHARMACEUTICALS IN 1.67%
OCULAR THERAPEUTIX INC 1.66%
OMEROS CORP 1.63%
COLLEGIUM PHARMACEUTICAL INC 1.62%
EYEPOINT INC 1.59%
SUPERNUS PHARMACEUTICALS INC 1.57%
TARSUS PHARMACEUTICALS INC 1.56%
NEKTAR THERAPEUTICS 1.51%
RAPPORT THERAPEUTICS INC 1.51%
CORMEDIX INC 1.45%
ALUMIS INC 1.44%
AMPHASTAR PHARMACEUTICALS IN 1.35%
THERAVANCE BIOPHARMA INC 1.34%
PRESTIGE CONSUMER HEALTHCARE 1.34%
SEPTERNA INC 1.24%
PHATHOM PHARMACEUTICALS INC 1.24%
ZOETIS INC 1.21%
ZEVRA THERAPEUTICS INC 1.13%
BIOAGE LABS INC 1.12%
ARVINAS INC 0.93%
MAZE THERAPEUTICS INC 0.91%
PHIBRO ANIMAL HEALTH CORP A 0.91%
LB PHARMACEUTICALS INC 0.77%
WAVE LIFE SCIENCES LTD 0.77%
AQUESTIVE THERAPEUTICS INC 0.76%
ALTO NEUROSCIENCE INC 0.44%
FULCRUM THERAPEUTICS INC 0.37%
SSI US GOV MONEY MARKET CLASS 0.07%
US DOLLAR 0%
Show more Hide
Other - %

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Other ETF & Funds from this provider

Similar ETF & Funds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} mln
    NAV
    {{ item.expense_ratio }}
    Total Cost Ratio
Registration is required to get access.